**Executive Summary**
On National Technology Day 2026 (May 11, 2026), the Indian Council of Medical Research (ICMR) participated in the ‘विज्ञा-Tech’ programme to showcase indigenous scientific excellence. The event served as a platform for the formal transfer of three ICMR-developed medical technologies to industry partners through licensing agreements. These initiatives support the "Make in Bharat" vision by fostering a self-reliant healthcare ecosystem and strengthening the medical innovation value chain.
**Key Points / Main Content**
* **Event Overview**
* The ‘विज्ञा-Tech’ programme brought together 14 Scientific Ministries and Departments at the BRIC–National Institute of Immunology, New Delhi.
* Coordinated by the Office of the Principal Scientific Adviser (PSA) and the Department of Biotechnology (DBT), the event adopted a "Whole-of-Government" approach.
* An official compendium was released featuring 25 promising technologies developed by various ICMR institutes.
* **ICMR Technology Showcase**
* ICMR exhibited six high-impact indigenous technologies, including Covaxin, a CRISPR-Cas-based TB Detection System, and a Nipah Point-of-Care Assay.
* The showcase spanned sectors such as Biopharma, Health, and Bioindustrial & Green Chemicals.
* **Licensed Technology Transfers**
* Three technologies were transferred to the private sector under the "Medical Innovations Patent Mitra" initiative:
* **Prostate Biopsy Guidance:** A cost-effective PSP94 ELISA for patients with PSA less than 20 ng/ml (licensed to Krishgen Labs Pvt. Ltd.).
* **Coagulation Diagnostics:** A Factor VIII Inhibitor / Coagulation Disorder Point-of-Care Diagnostic (licensed to Meril Life Sciences).
* **Viral Detection:** A Single-Tube Multiplex Real-Time RT-PCR for Dengue, Chikungunya, and Zika (licensed to Vanguard Life Sciences).
* **Strategic Objectives**
* The initiative focuses on protecting publicly funded innovations through structured intellectual property support.
* The goal is to enable the seamless translation of research into industry-ready solutions and promote indigenous manufacturing.
**Impact Analysis**
**Indian Council of Medical Research (ICMR) and Research Institutes**
**Impact**
Reinforces the organization's role in addressing national health priorities through diagnostics, medical devices, and disease surveillance. It validates their commitment to translational research and intellectual property protection.
**Action Required**
Continue developing indigenous innovations and facilitate technology transfers through the Medical Innovations Patent Mitra initiative.
**Industry Partners (Krishgen Labs, Meril Life Sciences, and Vanguard Life Sciences)**
**Impact**
These entities gain access to high-impact, indigenous medical technologies for commercialization and manufacturing.
**Action Required**
Execute the licensing agreements and manage the transition of these technologies into market-ready medical solutions.
**Scientific Ministries and Departments**
**Impact**
Enhanced collaboration among government, academia, and industry to build a robust innovation ecosystem.
**Action Required**
Collaborate across departments to support the "Viksit Bharat" vision and provide platforms for showcasing national technological advancements.
Key Entities Referenced
Indian Council of Medical Research (ICMR): The primary research body that developed and transferred three indigenous medical technologies to industry partners through licensing agreements.
विज्ञान–Tech (Vigyan-Tech): A national programme and exhibition that brings together 14 scientific ministries and departments to showcase India’s scientific excellence and innovations.
Medical Innovations Patent Mitra: An ICMR initiative designed to facilitate licensing agreements and the transfer of publicly funded innovations to industry-ready solutions.
Make in Bharat: A national vision aimed at promoting indigenous manufacturing, strengthening medical innovation, and fostering a self-reliant healthcare ecosystem.
Department of Health Research (DHR): The government department responsible for overseeing ICMR’s activities and contributions to national health priorities.
Ministry of Health and Family Welfare
ICMR transfers three Indigenous Medical
Technologies to Industry at National Technology
Day 2026
वान
National Technology Day Programme ‘ –Tech’ brings
together 14 Scientific Ministries and Departments to
showcase India’s Scientific Excellence and Technological
Advancements
Posted On: 11 MAY 2026 5:58PM by PIB Delhi
The Indian Council of Medical Research (ICMR) participated in the national programme ‘वान–Tech’,
organised on the occasion of National Technology Day 2026 at BRIC–National Institute of Immunology
(NII), New Delhi. Coordinated by the Office of the Principal Scientific Adviser (PSA) in collaboration
with the Department of Biotechnology (DBT), the programme reflected a Whole-of-Government
approach, bringing together 14 Scientific Ministries and Departments to celebrate India’s scientific
excellence and technological advancements.
The event was graced by the Union Minister of State (Independent Charge) for Science & Technology, Dr.
Jitendra Singh, who inaugurated the national technology exhibition and interacted with innovators and
exhibitors. Prof. Ajay Kumar Sood, Principal Scientific Adviser to the Government of India and Dr Rajiv
Behl, Secretary, Department of Health Research and DG ICMR, was also present on the occasion.
As part of its showcase, ICMR exhibited six high-impact indigenous technologies spanning the
Biopharma, Health, and Bioindustrial & Green Chemicals sectors. These included Covaxin, the COVID
Kavach ELISA Kit, a CRISPR-Cas-based TB Detection System, the Nipah Point-of-Care Assay, a
Diagnostic ELISA Kit for Dengue Detection, and a Biolarvicide for Mosquito Control.
In addition, 25 promising technologies and innovations developed by various ICMR institutes were
featured in the official compendium released during the event. These innovations highlighted ICMR’s
significant contributions in diagnostics, medical devices, digital health, disease surveillance, and
translational research, reinforcing its commitment to addressing national health priorities through
indigenous research and innovation.
A major highlight of the programme was the transfer of three ICMR-developed technologies to industry
partners through licensing agreements facilitated under the Medical Innovations Patent Mitra initiative of
ICMR.
The first technology, titled “Development of a Cost-Effective PSP94 ELISA for Guiding Prostate Biopsy
Decisions in Patients with PSA less than 20 ng/ml,” was developed by Dr. Dhanashree Jagtap, Dr. Smita
Mahale, and Dr. Bhakti Pathak at ICMR–National Institute for Research in Women’s Health (ICMR-
NIRWoH). The technology was licensed to Krishgen Labs Pvt. Ltd.The second technology transfer involved a “Factor VIII Inhibitor / Coagulation Disorder Point-of-Care
Diagnostic,” developed by Dr. Rucha Patil at ICMR–National Institute for Research on Blood and
Immune Disorders (ICMR-NIRBID). The technology was licensed to Meril Life Sciences.
The third technology, “Single-Tube Multiplex Real-Time RT-PCR for Detection of Dengue, Chikungunya,
and Zika Viruses,” was developed by Dr. Alagarasu K at ICMR–National Institute of Virology (ICMR-
NIV) and licensed to Vanguard Life Sciences.
These technology transfers were undertaken during the National Technology Transfer and MoU Exchange
Session, held alongside the release of a national compendium showcasing technologies developed by
autonomous institutes and laboratories of participating Ministries and Departments.
The successful transfer of these technologies underscores ICMR’s commitment to protecting publicly
funded innovations through structured intellectual property support while enabling their seamless
translation into industry-ready solutions. The initiative aligns with the vision of Make in Bharat by
promoting indigenous manufacturing, strengthening the medical innovation value chain, and fostering a
self-reliant healthcare ecosystem.
The ‘वान–Tech’ programme served as a national platform for showcasing technologies developed by
India’s premier research institutions and for strengthening collaboration among government, academia,
and industry. The event reaffirmed the collective resolve of scientific Ministries and Departments to build
a robust innovation ecosystem in support of the vision of Viksit Bharat.***
SR/GS
(Release ID: 2259926) Visitor Counter : 559
Read this release in: Urdu , ही